Predict your next investment

HEALTHCARE
coridea.com

See what CB Insights has to offer

About Coridea

Provider of consulting and incubator services for medical startups in the cardio-renal and cardio-pulmonary fields. The company is an idea generator, technology incubator, and consulting firm that applies established technologies to new targets in the cardio-renal and cardio-pulmonary fields. [Keywords: biotech]

Coridea Headquarter Location

134 West 26th Street Suite 1011

New York, New York, 10001,

United States

(212)929-6600

Latest Coridea News

Coridea and Deerfield team up to launch East Coast med-tech incubator

Mar 17, 2021

All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Coridea Patents

Coridea has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac anatomy
  • Cardiac arrhythmia
  • Cardiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/11/2016

11/24/2020

Cardiac arrhythmia, Rare diseases, Cardiac anatomy, Cardiovascular physiology, Cardiology

Grant

Application Date

5/11/2016

Grant Date

11/24/2020

Title

Related Topics

Cardiac arrhythmia, Rare diseases, Cardiac anatomy, Cardiovascular physiology, Cardiology

Status

Grant

Coridea Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Coridea Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.